Search engine for discovering works of Art, research articles, and books related to Art and Culture
Javascript must be enabled to continue!
Studies on PIVKA-X
View through CrossRef
SummaryThe incorporation of 14C-glucosamine and 3H-leucine into PIVKA-X and factor X has been studied in Macaca mulatta by means of a monospecific precipitating antiserum. No difference in the incorporation into PIVKA-X and factor X was found.The half-lives of PIVKA-X and factor X were similar (about 30-35 h and 27-31 h respectively) indicating that the vitamin K-induced modifications did not alter the survival of protein.A Russell’s-viper venom/cephalin test system for factor X was more sensitive to inhibition by PIVKA-X than was a tissue thromboplastin-based system.
Title: Studies on PIVKA-X
Description:
SummaryThe incorporation of 14C-glucosamine and 3H-leucine into PIVKA-X and factor X has been studied in Macaca mulatta by means of a monospecific precipitating antiserum.
No difference in the incorporation into PIVKA-X and factor X was found.
The half-lives of PIVKA-X and factor X were similar (about 30-35 h and 27-31 h respectively) indicating that the vitamin K-induced modifications did not alter the survival of protein.
A Russell’s-viper venom/cephalin test system for factor X was more sensitive to inhibition by PIVKA-X than was a tissue thromboplastin-based system.
Related Results
PIVKA-II correlates with INR but not protein C or protein S concentrations in cord blood among newborns
PIVKA-II correlates with INR but not protein C or protein S concentrations in cord blood among newborns
BACKGROUND: Protein induced by vitamin K absence (PIVKA)-II, inactive precursor of prothrombin, is elevated in vitamin K (VK) deficiency. Our aims were to find the prevalence of VK...
Longitudinal surveillance of three biomarkers to predict recurrence of hepatocellular carcinoma after radical resection
Longitudinal surveillance of three biomarkers to predict recurrence of hepatocellular carcinoma after radical resection
Abstract
Background: Radical resection is a curative treatment for patients with hepatocellular carcinoma (HCC), but the incidence of recurrence remains high. We aimed to e...
PIVKA‑II value in the diagnosis of hepatocellular carcinoma in patients with inconclusive imaging findings or AFP levels.
PIVKA‑II value in the diagnosis of hepatocellular carcinoma in patients with inconclusive imaging findings or AFP levels.
Objective: To evaluate the diagnostic accuracy of Protein Induced by Vitamin K Absence-II (PIVKA‑II; des-γ-carboxy prothrombin) in patients with suspected HCC who had nondiagnostic...
Strateška lega zgornje Pivke
Strateška lega zgornje Pivke
Zgornja Pivka je že večkrat v zgodovini odigrala pomembno vlogo prav zaradi svoje strateške lege. Nazadnje se je to pokazalo po prvi svetovni vojni, ko je z uveljavitvijo Rapallske...
Tectonic Sights of the Pivka Basin
Tectonic Sights of the Pivka Basin
Čez Pivško kotlino poteka pomemben regionalni nariv, nariv Snežnika, ki loci Snežniško narivno grudo od paravtohtona Komenske narivne grude. Tektonsko okno pri Knežaku je dokaz st...
Establishment of PIVKA-Ⅱ Reference Intervals From Hospital-stored Data: A Comparison Analysis
Establishment of PIVKA-Ⅱ Reference Intervals From Hospital-stored Data: A Comparison Analysis
Abstract
Objective The authors aimed to explore methods to establish indirect reference intervals for PIVKA-II from hospital-stored data.Method 7623 patient specimens of th...
Housing Improvements for Health and Associated Socio‐Economic Outcomes: A Systematic Review
Housing Improvements for Health and Associated Socio‐Economic Outcomes: A Systematic Review
Poor housing is associated with poor health. This suggests that improving housing conditions might lead to improved health for residents. This review searched widely for studies fr...
Small Cell Lung Cancer and Tarlatamab: A Meta-Analysis of Clinical Trials
Small Cell Lung Cancer and Tarlatamab: A Meta-Analysis of Clinical Trials
Abstract
Introduction
Tarlatamab is a Delta-like ligand 3 (DLL3) -directed bispecific T-cell engager recently approved for use in patients with advanced small cell lung cancer (SCL...